Literature DB >> 2550755

Immunological diagnosis in viral infections of the central nervous system: course of antibody titres against homo- and heterologous viruses.

R H Dennin1, E Herb.   

Abstract

In clinical cases suspected for viral encephalitis or meningoencephalitis, the estimation of virus-specific antibodies especially in liquor requires high sensitivity as well as specificity. With enzyme immunoassays the sensitivity in detecting antibodies has increased compared to e.g., complement fixation tests. This report concerns the determination of virus-specific antibodies with a commercial enzyme-linked immunosorbent assay (ELISA) in paired liquor/serum samples of four patients with encephalitis or meningoencephalitis. Up to six virus-specific antibodies of the IgG and IgM classes have been determined [herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus, mumps virus, measles virus, and rubella virus]. Additionally, serum samples from several patients suffering, or recovered from, diseases caused by HSV and VZV without CNS involvement have been included as controls. The results showed that besides the virus-specific antibody development (IgG and IgM) against the leading virus, i.e., principally concerned in the disease manifestation assumed to be primarily causing the disease, virus-specific antibodies of the IgG and IgM class against a heterologous virus (e.g., VZV) could also be measured with substantial titers. "Cross-reacting" antibodies to both HSV and VZV with the ELISA only appeared and were present in cases where the infection mainly affected the CNS: no such immunological "cross-reactivity" was observed in serum of individuals in "clinically silent" stages of both HSV and VZV infections. The same situation with no measurable "cross-reacting" antibodies was found in cases of acute HSV or VZV diseases where the CNS was not involved. These findings have been discussed with respect to the findings of common antigens, especially between HSV and VZV, and with respect to an unspecific stimulation of immunocompetent cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550755     DOI: 10.1007/BF00191060

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  28 in total

1.  Autoantibodies in herpesvirus infections.

Authors:  P Wutzler; I Färber; A Ulbricht
Journal:  Acta Virol       Date:  1978-07       Impact factor: 1.162

2.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

3.  Simultaneous rise in complement-fixing antibodies against herpesvirus hominis and varicella-zostervirus in patients with chickenpox and shingles.

Authors:  G J Schaap; J Huisman
Journal:  Arch Gesamte Virusforsch       Date:  1968

4.  Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis.

Authors:  R Whitley; A D Lakeman; A Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1982-10-21       Impact factor: 91.245

5.  Recovery of latent herpes simplex virus from human trigeminal nerve roots.

Authors:  K G Warren; R G Marusyk; M E Lewis; V M Jeffrey
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Antigenic relationship of varicella-zoster and herpes simplex.

Authors:  C A Ross; J H Subak Sharpe; P Ferry
Journal:  Lancet       Date:  1965-10-09       Impact factor: 79.321

7.  Detection of herpes-simplex viral genome in brain tissue.

Authors:  L W Sequiera; L C Jennings; L H Carrasco; M A Lord; A Curry; R N Sutton
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

8.  Varicella-zoster virus RNA in human trigeminal ganglia.

Authors:  R W Hyman; J R Ecker; R B Tenser
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

9.  Herpes simplex virus encephalitis: intrathecal synthesis of oligoclonal virus-specific IgG, IgA and IgM antibodies.

Authors:  B Vandvik; F Vartdal; E Norrby
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

10.  Herpes simplex type 1 DNA in human brain tissue.

Authors:  N W Fraser; W C Lawrence; Z Wroblewska; D H Gilden; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  2 in total

Review 1.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Authors:  S Jarius; P Eichhorn; D Franciotta; H F Petereit; G Akman-Demir; M Wick; B Wildemann
Journal:  J Neurol       Date:  2016-12-22       Impact factor: 4.849

2.  The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system.

Authors:  K Felgenhauer; H Reiber
Journal:  Clin Investig       Date:  1992-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.